| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Gaston TR, Rasmussen GT |
Identification of 3,4 methylenedioxymethamphetamine |
Bureau of Narcotics ... |
1972 |
| Sreenivasan VR |
Problems in Identification of Methylenediony and Methoxy Amphetamines |
Journal of Criminal ... |
1972 |
| Caldwell J, Sever PS |
The biochemical pharmacology of abused drugs 1. Amphetamines, cocaine,... |
Clin.Pharmacol.Ther. |
1974 |
| Kataoka Y, Shibata K, Fuj... |
Effects of psychotropic drugs on labor division between rats |
Japan. J. Pharmacol. |
1978 |
| Decker WJ, Brandes WB |
LSD Misadventure in Middle Age |
J. Forens. Sci. |
1978 |
| Murdock JE, Shulgin AT |
A novel illicit amphetamine laboratory |
Microgram |
1978 |
| Lyon RA, Glennon RA, Tite... |
3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions... |
Psychopharmacology (... |
1986 |
| Shulgin AT |
The background and chemistry of MDMA |
J Psychoactive Drugs |
1986 |
| Siegel RK |
MDMA-Nonmedical use and intoxication |
J Psychoactive Drugs |
1986 |
| Glennon RA, Yousif M, Nai... |
Methcathinone: a new and potent amphetamine-like agent |
Pharmacol Biochem Be... |
1987 |
| Battaglia G, Yeh SY, O'He... |
3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine de... |
J Pharmacol Exp Ther |
1987 |
| Davis WM, Hatoum HT, Wate... |
Toxicity of MDA (3,4-methylenedioxyamphetamine) considered for relevan... |
Alcohol Drug Res |
1987 |
| Lamb RJ, Griffiths RR |
Self-injection of d,1-3,4-methylenedioxymethamphetamine (MDMA) in the ... |
Psychopharmacology (... |
1987 |
| Peroutka SJ, Pascoe N, Fa... |
Monoamine metabolites in the cerebralspinal fluid of recreational user... |
Research Comm in Sub... |
1987 |
| Oberlender R, Nichols DE |
Drug discrimination studies with MDMA and amphetamine |
Psychopharmacology (... |
1988 |
| Peroutka SJ, Newman H, Ha... |
Subjective effects of 3,4-methylenedioxymethamphetamine in recreationa... |
Neuropsychopharmacol... |
1988 |
| Pierce PA, Peroutka SJ |
Ring-substituted amphetamine interactions with neurotransmitter recept... |
Neurosci Lett |
1988 |
| Ramos JM Jr, Fitzgerald R... |
MDMA and MDA cross reactivity observed with Abbott TDx amphetamine/met... |
Clin Chem |
1988 |
| Scallet AC, Lipe GW, Ali ... |
Neuropathological evaluation by combined immunohistochemistry and dege... |
Neurotoxicology |
1988 |
| Price LH, Ricaurte GA, Kr... |
Neuroendocrine and mood responses to intravenous L-tryptophan in 3,4-m... |
Arch Gen Psychiatry |
1989 |
| Gold LH, Koob GF |
MDMA produces stimulant-like conditioned locomotor activity |
Psychopharmacology (... |
1989 |
| Hekmatpanah CR, McKenna D... |
Reserpine does not prevent 3,4-methylenedioxymethamphetamine-induced n... |
Neurosci Lett |
1989 |
| Peroutka SJ |
'Ecstasy': a human neurotoxin? |
Arch Gen Psychiatry |
1989 |
| Price LH, Ricaurte GA, Kr... |
Responses to I.V. L-tryptophan in MDMA Users |
NIDA Res Monogr |
1989 |
| Schmidt CJ |
Acute and long-term neurochemical effects of methylenedioxymethampheta... |
NIDA Res Monogr |
1989 |
| Hashimoto K, Goromaru T |
Reduction of [3H]6-nitroquipazine-labelled 5-hydroxytryptamine uptake ... |
Fundam Clin Pharmaco... |
1990 |
| Hekmatpanah CR, Peroutka ... |
5-hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine-... |
Eur J Pharmacol |
1990 |
| McKenna DJ, Peroutka SJ |
Neurochemistry and neurotoxicity of 3,4-methylenedioxymethamphetamine ... |
J Neurochem |
1990 |
| Scheffel U, Ricaurte GA |
Paroxetine as an in vivo indicator of 3,4-methylenedioxymethamphetamin... |
Brain Res |
1990 |
| Schmidt CJ, Kehne JH |
Neurotoxicity of MDMA: neurochemical effects |
Ann N Y Acad Sci |
1990 |
| Sprouse JS, Bradberry CW,... |
3,4-Methylenedioxymethamphetamine-induced release of serotonin and inh... |
Eur J Pharmacol |
1990 |
| McKenna DJ, Guan XM, Shul... |
3,4-Methylenedioxyamphetamine (MDA) analogues exhibit differential eff... |
Pharmacol Biochem Be... |
1991 |
| Battaglia G, Sharkey J, K... |
Neuroanatomic specificity and time course of alterations in rat brain ... |
Synapse |
1991 |
| Hiramatsu M, DiStefano E,... |
A pharmacokinetic analysis of 3,4-methylenedioxymethamphetamine effect... |
Eur J Pharmacol |
1991 |
| Henry JA, Jeffreys KJ, Da... |
Toxicity and deaths from 3,4-methylenedioxymethamphetamine ('ecstasy') |
Lancet |
1992 |
| Grob CS, Bravo GL, Walsh ... |
The MDMA-neurotoxicity controversy: implications for clinical research... |
J Nerv Ment Dis |
1992 |
| Henry JA |
Ecstasy and the dance of death |
BMJ |
1992 |
| McCann UD, Ricaurte GA |
MDMA ('ecstasy') and panic disorder: induction by a single dose |
Biol Psychiatry |
1992 |
| Ricaurte GA, Martello AL,... |
Lasting effects of (+-)-3,4-methylenedioxymethamphetamine (MDMA) on ce... |
J Pharmacol Exp Ther |
1992 |
| Scheffel U, Lever JR, Sta... |
Repeated administration of MDMA causes transient down-regulation of se... |
Neuropharmacology |
1992 |
| Steele TD, Katz JL, Ricau... |
Evaluation of the neurotoxicity of N-methyl-1-(4-methoxyphenyl)-2-amin... |
Brain Res |
1992 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Ali SF, Newport GD, Scall... |
Oral administration of 3,4-methylenedioxymethamphetamine (MDMA) produc... |
Neurotoxicol Teratol |
1993 |
| Hermle L, Spitzer M, Borc... |
Psychological effects of MDE in normal subjects. Are entactogens a new... |
Neuropsychopharmacol... |
1993 |
| Scanzello CR, Hatzidimitr... |
Serotonergic recovery after (+/-)3,4-(methylenedioxy) methamphetamine ... |
J Pharmacol Exp Ther |
1993 |
| Fitzgerald JL, Reid JJ |
Sympathomimetic Actions of Methylenedioxymethamphetamine in Rat and Ra... |
J Pharm Pharmacol |
1994 |
| George S, Braithwaite RA |
Drugs of abuse screening in the West Midlands: a 6 year retrospective ... |
Ann Clin Biochem |
1994 |
| Millman RB, Beeder AB |
The new psychedelic culture: LSD, ecstasy, 'rave' parties and the Grat... |
Psychiatric Annals |
1994 |
| Ward C, McNally AJ, Rusyn... |
125I radioimmunoassay for the dual detection of amphetamine and metham... |
J Forensic Sci |
1994 |
| Wotherspoon G, Savery D, ... |
Repeated administration of MDMA down-regulates preprocholecystokinin m... |
Brain Res Mol Brain ... |
1994 |
| Aguirre N, Galbete JL, La... |
Methylenedioxymethamphetamine induces opposite changes in central pre-... |
Eur J Pharmacol |
1995 |
| Hegadoren KM, Baker GB, C... |
Analysis of the enantiomers of 3,4-methylenedioxy-N-ethylamphetamine (... |
J Pharmacol Toxicol ... |
1995 |
| Sprague JE, Nichols DE |
The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-meth... |
J Pharmacol Exp Ther |
1995 |
| Green AR, Goodwin GM |
Ecstasy and neurodegeneration |
BMJ |
1996 |
| Kunsman GW, Levine B, Kuh... |
MDA-MDMA concentrations in urine specimens |
J Anal Toxicol |
1996 |
| Helmlin HJ, Bracher K, Bo... |
Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolit... |
J Anal Toxicol |
1996 |
| Jagust WJ, Eberling JL, B... |
Iodine-123-5-iodo-6-nitroquipazine: SPECT radiotracer to image the ser... |
J Nucl Med |
1996 |
| White SR, Obradovic T, Im... |
The effects of methylenedioxymethamphetamine (MDMA, 'Ecstasy') on mono... |
Prog Neurobiol |
1996 |
| Vorhees CV |
Methods for detecting long-term CNS dysfunction after prenatal exposur... |
Drug Chem Toxicol |
1997 |
| Schwartz RH, Miller NS |
MDMA (ecstasy) and the rave: a review |
Pediatrics |
1997 |
| Tsatsakis AM, Michalodimi... |
MDEA related death in Crete: a case report and literature review |
Vet Hum Toxicol |
1997 |
| Kintz P, Cirimele V |
Interlaboratory comparison of quantitative determination of amphetamin... |
Forensic Sci Int |
1997 |
| Huether G, Zhou D, Ruther... |
Causes and consequences of the loss of serotonergic presynapses elicit... |
J Neural Transm |
1997 |
| Ropero-Miller JD, Goldber... |
Recreational drugs. Current trends in the 90s |
Clin Lab Med |
1998 |
| Ramseier A, Caslavska J, ... |
Screening for urinary amphetamine and analogs by capillary electrophor... |
Electrophoresis |
1998 |
| Aguirre N, Barrionuevo M,... |
The role of dopaminergic systems in the perinatal sensitivity to 3, 4-... |
J Pharmacol Exp Ther |
1998 |
| Bengel D, Murphy DL, Andr... |
Altered brain serotonin homeostasis and locomotor insensitivity to 3, ... |
Mol Pharmacol |
1998 |
| Cadet JL, Brannock C |
Free radicals and the pathobiology of brain dopamine systems |
Neurochem Int |
1998 |
| Sprague JE, Everman SL, N... |
An integrated hypothesis for the serotonergic axonal loss induced by 3... |
Neurotoxicology |
1998 |
| Bilsky EJ, Montegut MJ, N... |
CGS 10746B, a novel dopamine release inhibitor, blocks the establishme... |
Pharmacol Biochem Be... |
1998 |
| Young R, Glennon RA |
Discriminative stimulus properties of (-)ephedrine |
Pharmacol Biochem Be... |
1998 |
| Scheffel U, Szabo Z, Math... |
In vivo detection of short- and long-term MDMA neurotoxicity--a positr... |
Synapse |
1998 |
| Henry JA, Hill IR |
Fatal interaction between ritonavir and MDMA |
Lancet |
1998 |
| McCann UD, Szabo Z, Schef... |
Positron emission tomographic evidence of toxic effect of MDMA ('Ecsta... |
Lancet |
1998 |
| Gouzoulis-Mayfrank E, The... |
Modulation of semantic priming effects by psilocybin, MDE (ecstasy) an... |
Neurology Psychiatry... |
1998 |
| O'Connell D, Heffron JJ |
Rapid analysis of illicit drugs by mass spectrometry: results from sei... |
Analyst |
1999 |
| Bogusz MJ, Maier RD, Krug... |
Poor reproducibility of in-source collisional atmospheric pressure ion... |
J Chromatogr A |
1999 |
| Holland J |
Positron emission tomography findings in heavy users of MDMA |
Lancet |
1999 |
| Ramseier A, Caslavska J, ... |
Stereoselective screening for and confirmation of urinary enantiomers ... |
Electrophoresis |
1999 |
| Stumm G, Schlegel J, Scha... |
Amphetamines induce apoptosis and regulation of bcl-x splice variants ... |
FASEB J |
1999 |
| Rochester JA, Kirchner JT |
Ecstasy (3,4-methylenedioxymethamphetamine): history, neurochemistry, ... |
J Am Board Fam Pract |
1999 |
| Kintz P, Samyn N |
Determination of 'Ecstasy' components in alternative biological specim... |
J Chromatogr B Biome... |
1999 |
| Mas M, Farre M, de la Tor... |
Cardiovascular and neuroendocrine effects and pharmacokinetics of 3, 4... |
J Pharmacol Exp Ther |
1999 |
| Schirren CA, Berghaus TM,... |
Thrombotic thrombocytopenic purpura after Ecstasy-induced acute liver ... |
Ann Intern Med |
1999 |
| Aguirre N, Barrionuevo M,... |
Alpha-lipoic acid prevents 3,4-methylenedioxy-methamphetamine (MDMA)-i... |
Neuroreport |
1999 |
| Stephenson CP, Hunt GE, T... |
The distribution of 3,4-methylenedioxymethamphetamine 'Ecstasy'-induce... |
Neuroscience |
1999 |
| Mintzer S, Hickenbottom S... |
Parkinsonism after taking ecstasy [Comment & Reply] |
N Engl J Med |
1999 |
| Kidwell DA, Smith FP |
Susceptibility of PharmChek Drugs of Abuse Patch to Environmental Cont... |
Naval Research Labor... |
1999 |
| Baggott M, Heifets B, Jon... |
Chemical analysis of ecstasy pills |
JAMA |
2000 |
| McFee RB, Mofenson HC, Ca... |
Dextromethorphan: Another 'Ecstasy'? |
Arch Fam Med |
2000 |
| Parrott AC, Sisk E, Turne... |
Psychobiological problems in heavy `ecstasy' (MDMA) polydrug users |
Drug Alcohol Depend |
2000 |
| Aalberg L, DeRuiter J, No... |
Chromatographic and Mass Spectral Methods of Identification for the Si... |
J Chromatogr Sci |
2000 |
| Fischer HS, Zernig G, Sch... |
MDMA ('ecstasy') enhances basal acetylcholine release in brain slices ... |
Eur J Neurosci |
2000 |
| Heinz A, Jones DW |
Serotonin transporters in ecstasy users |
Br J Psychiatry |
2000 |
| Jurado C, Gimenez MP, et ... |
Rapid analysis of amphetamine, methamphetamine, MDA, and MDMA in urine... |
J Anal Toxicol |
2000 |
| Russell BR, Laverty R |
Correlation between 5-HT content and uptake site density following (S)... |
Ann N Y Acad Sci |
2000 |
| Anderson C |
Water intake probed in death |
Boulder Daily Camera |
2001 |
| Zhao H, Brenneisen R, Sch... |
Profiles of urine samples taken from Ecstasy users at Rave parties: an... |
J Anal Toxicol |
2001 |
| Heffernan TM, Jarvis H, R... |
Prospective memory, everyday cognitive failure and central executive f... |
Hum Psychopharm Clin... |
2001 |
| Logan BK, Couper FJ |
3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairme... |
J Forensic Sci |
2001 |
